Radiation leukemia virus, isolated from radiation-induced lymphomas in C57BL/Ka mice and propagated in that strain, is thymotropic and leukemogenic in vivo but replicates poorly, if at all, in mouse and mink fibroblast cultures in vitro. Comparative studies indicate that this naturally occurring virus is distinct from the previously recognized classes of endogenous murine ecotropic and xenotropic C-ype viruses which are capable of replication on fibroblasts (fibrotropic) but are neither thymotropic nor leukemogenic. These studies also demonstrate that a differentiation-specific restriction system governing the replication of the murine ecotropic C-type viruses operates in addition to the previously defined Fv-1 and SRV gene restriction systems. Radiation leukemia virus (RadLV), a naturally occurring murine leukemogenic virus, is recovered from thymic lymphomas induced by x-irradiation in strain C57BL/Ka mice (1, 2). This virus replicates selectively in the host thymus (3, 4). Mice of strain C57BL have also been shown to harbor three classes of endogenous C-type viruses, all of which can be propagated on fibroblastic cells in vitro but differ in host range. They include B-tropic (5, 6), N-tropic (6, 7), and X-tropic viruses (8, 9) . It is now reported that the thymotropic, leukemogenic particles in RadLV differ at the molecular level, as revealed by their antigenic determinants, from the B, N, and X endogenous viruses and from any combination thereof, and must therefore be recognized as a distinctive subclass of murine ecotropic viruses.
MATERIALS AND METHODS
Mice. C57BL/Ka mice of both sexes, 3-5 weeks of age, were obtained from our own colony. NIH/Swiss mice were kindly provided by Dr. Paul Arnstein, National Cancer Institute, California State Department of Health, Berkeley, Calif.
Viruses. RadLV was prepared as 20% extracts of RadLVinduced C57BL/Ka thymomas in phosphate-buffered saline, as previously described (1) . Two such extracts prepared on 10-28-74 and 3-27-75 were used in these experiments. BL/Ka (6) virus was obtained from the supernatant of an established C57BL/Ka fibroblast line, (RadLV), after more than 20 passages of that line in vitro following infection by RadLV. BL/Ka(B) clone 1 was derived from the supernatant of cultures of C57BL/Ka mouse embryo fibroblasts after infection by limiting dilutions of RadLV .that had been treated with antiserum to Balb:virus-2. BL/Ka(N) was obtained from the supernatant of a culture of NIH/Swiss mouse embryo fibroblasts at the 20th passage after infection by a tissue extract of radiation-induced lymphoma (7) . BL/Ka(X) was derived from mink lung cells that became productively infected after cocultivation with normal thymic cells from C57BL/Ka mice. AKR murine leukemia virus (MuLV) was isolated from an established line of AKR mouse embryo fibroblasts that spontaneously initiated virus replication. BL/6(B) and BL/6(N) viruses were isolated from SC-1 cells infected with endogenous C57BL/6 B-and N-tropic viruses, respectively. Balb/c(X) virus was obtained from cultures of mink lung cells infected with the xenotropic Balb:virus-2. The last three virus preparations were kindly provided by Dr. Janet Hartley (National Institutes of Health, Bethesda, Md.).
Cells. Primary and secondary cultures of mouse embryo fibroblasts (MEF) were prepared as described (10) Neutralization Assays. All sera were heat-inactivated at 560 for 30 min. The sera included: (a) serum from normal 3-to 4-month-old C57BL/Ka mice; (b) pig anti-Balb:virus-2 (Ki-MSV) ("anti-xenotropic") serum, lot 4S-0422 from Huntington Labs, Brooklandville, Md.; (c) guinea pig anti-amphotropic 1504-A serum (kindly provided by Dr. R. V. Gilden, NCI Frederick Cancer Research Center, Frederick, Md.), which has a neutralization titer for the amphotropic 1504-A virus of 1:160 (14) ; (d) rabbit anti-AKR-MuLV gp7l ("anti-ecotropic") serum; and (e) rabbit anti-Rauscher-MuLV gp7l, which has a neutralization titer for Rauscher virus of 1:1600. The last two sera were prepared using proteins purified from the respective viruses as described (15) . Equal volumes of serial dilutions of antiserum were mixed with virus dilutions that would induce 20% immunofluorescence-positivity in the test cells for the neutralization assay in vitro, or as indicated in Table 3 for the neutralization assay in vivo. The mixtures of virus and serum were then held at room temperature for 1 hr and at 40 for another hour. Controls were treated in the same way in fetal calf serum (Microbiological Associates, Bethesda, Md.).
The serum-treated viruses were then injected intrathymically into animals or assayed in cell cultures in vitro. The results represent mean values of two or more separate experiments. Antibody titers are expressed as the reciprocal of the highest serum dilution that gave more than a 66% reduction in the percentage of immunofluorescence-positive cells, as compared to controls treated with fetal calf serum.
Abbreviations: RadLV, radiation leukemia virus; MuLV, murine leukemia virus; MEF, mouse embryo fibroblasts. 4675 (16) . The assay for AKR-MuLV gp7l used 125I-labeled were typical of, respectively, B-, N-, and X-tropic viruses. When AKR-MuLV gp7l and its homologous antisera. The assays for immunofluorescence-positive mink cells were tested in the p12 and p30 used '25I-labeled AKR MuLV p12 and p30 and reverse XC assay, plaque formation was not detected, conmonospecific rabbit antisera prepared against these proteins.
firming the observation by others (9) (17) , neutralizing titer of the anti-Balb:virus-2 serum for BL/Ka(X) RadLV was found to be strongly thymotropic as well as B-tropic clearly established the xenotropic nature of this virus. This with respect to the Fv-1 host restriction system (18, 19) . It grew serum also neutralized the infectivity of RadLV and BL/Ka(6) to low titers on fibroblasts in vitro, but maintained its B-tropic on mink lung cells, confirming the presence of a xenotropic nature. In addition, some xenotropic activity was detected on component in these preparations. Some neutralization of mink cells.
BL/Ka(X) was also observed with normal C57BL serum; this BL/Ka(6), also a B-tropic isolate, was, in contrast to RadLV, was reported by others (22, 23) to be due to a nonimmunoglobin highly fibrotropic in vitro and replicated to low titers in vivo.
factor (24, 25) that reacts specifically with xenotropic viIts xenotropic activity was similar to that of RadLV. ruses. The BL/Ka(B) clone 1, BL/Ka(N), or BL/Ka(X) isolates It is evident that RadLV stands apart from other endogenous viruses, since no significant neutralization of its ecotropic infectivity was obtained with any of the specific antisera tested. That this is not due to protection of the virus by the high protein content of the tissue extract is indicated by the fact that the infectivity of RadLV on mink cells could be readily neutralized by the anti-Balb:virus-2 serum and that mixing BL/Ka(6) with 20% normal thymus-spleen extract did not prevent its neutralization by the anti-AKR gp7l serum.
In vivo studies (Table 3) confirmed that high dilutions of RadLV were not neutralized by the various sera tested, with the exception of the anti-Balb:virus-2 serum, which had slight neutralizing activity. At the 1:10 dilution, BL/Ka(6) virus, which shows low titers in vivo, could not be significantly neutralized by the antisera tested; higher dilutions were, however, neutralized by both the anti-AKR gp7l and the anti-Balb: virus-2 sera. The antiserum prepared against an amphotropic virus, 1504-A, of the wild mouse (14) did not neutralize any of the virus preparations tested in vivo or in vitro.
Radioimmune Competition Assay. The serological characteristics of RadLV, BL/Ka(6), BL/Ka(N), and BL/Ka(X) viruses were compared to those of other virus isolates by radioimmune competition assays. Viruses purified by sucrose gradient centrifugation or extracts of cells replicating the appropriate virus were used. The results of assays using radioiodinated AKR-MuLV gp7l and antiserum against this glycoprotein are illustrated in Fig. 1A . Whereas the BL/Ka(6), BL/Ka(N), BL/6(N), and BL/6(B) isolates competed completely and equivalently against AKR-MuLV gp7l, no competition was observed with the two RadLV preparations, or with the BL/Ka(X) and Balb/c xenotropic viruses. This demonstrates that the glycoprotein of RadLV is serologically distinct from that of the endogenous ecotropic, fibrotropic viruses. Fig. 1B illustrates the results obtained in competition assays using radioiodinated AKR-MuLV p30. Complete and equivalent competition was observed for all of the virus preparations. In  Fig. IC , the results obtained with a competition assay for AKR-MuLV p12 are presented. Only BL/Ka(N) and the BL/6(N) viruses competed completely and equivalently against AKR-MuLV p12. This was expected since this p12 is typespecific for (N)-ecotropic viruses (J. N. Ihle, unpublished observation). Thus, the results of radioimmune competition with the AKR-MuLV gp71, p30, and p12 standards demonstrate that BL/Ka(6) and BL/Ka(N) compete as standard endogenous Band N-ecotropic, fibrotropic viruses, that the BL/Ka(X) preparation is homogeneously xenotropic, since it does not contain detectable levels of ecotropic gp7l antigen, and that RadLV seems to be clearly different from the endogenous fibrotropic viruses, as demonstrated by its lack of competition with AKR-MuLV gp7l glycoprotein.
In competition assays using radioiodinated Balb:virus-2 gp7l and an antiserum against C57L xenotropic virus, Balb:virus-2 xenotropic virus competed completely, whereas AKR virus, BL/Ka(6) virus, and cell extracts of BL/Ka(N) virus-producing cells competed poorly against Balb:virus-2 gp7l (Fig. 2) (6) (26) , it was noted that the progeny virus, after several passages, had lost all its leukemogenicity. This was initially interpreted as the result of "modulation" or selection in the intracellular environment of the fibroblast (26) . Haas and HIilgers (27) RadLV on C57BL/Ka MEF cultures is an assay of a biological effect rather than replication since the resulting virus preparations have lost both the serological characteristics associated with RadLV and the ability to induce thymic lymphomas.
The apparent serological uniqueness of the thymotropic, leukemogenic RadLV is particularly relevant to recent studies of virus expression in primary, radiation-induced thymic lymphomas in C57BL/6 mice (29). In particular, these studies demonstrated that there was no serological correlation between a humoral immune response against endogenous ecotropic fibrotropic viruses and leukemia. Moreover, using competition assays and RNA-DNA hybridization, there was no evidence of overt ecotropic or xenotropic virus expression in the majority of thymomas. These studies must now be re-examined after the serological characteristics of RadLV are determined and the assays for the specific detection of this virus are developed. The relationship of RadLV with the AKR Gross virus in terms of its serological properties (30, 31) will also require reconsideration in the light of the present data.
Finally, it is clear that a differentiation-specific restriction system governing the replication of the murine ecotropic C-type viruses operates in addition to the existing Fv-1 and SRV gene restriction systems. The thymotropic-leukemogenic viruses replicate selectively in mouse thymic lymphocytes in vivo, whereas viruses of the other subclass replicate preferentially in mouse fibroblasts in vitro. However, both subclasses are subject to control by the Fv-I (18, 19) and SRV (17) genes. These findings focus attention on the desirability of propagating candidate leukemia-lymphoma viruses in lymphoid rather than fibroblastic cells to preserve their leukemogenicity. Moreover, it no longer seems appropriate-to use the term "murine leukemia viruses" for C-type murine viruses that have not been shown to be leukemogenic.
